The present invention provides compounds of Formula (I) and ester
prodrugs, pharmaceutically acceptable salts or solvates of such
compounds; or ester prodrugs of such salts or solvates; pharmaceutical
compositions comprising such compounds, their preparation, and their
pharmaceutical use in the treatment of disease states capable of being
modulated by the inhibition of p38 kinase and/or tumor necrosis factor
(TNF).